News – Page 891 – Endpoints News

Alexion clinches aHUS approval for Ultomiris as the clock ticks on Soliris conversion

6 years ago

IMbrave150: Roche’s regulatory crew plans a global rollout of Tecentriq combo for liver cancer as PhIII scores a ...

6 years ago

FDA approval lets Foamix set its maiden acne therapy on course for US market launch

6 years ago

Clay Siegall’s $614M wager on tucatinib pays off with solidly positive pivotal data and a date with the FDA

6 years ago

Armed with Langer tech and $50M, Verseau hails new checkpoint drugs unleashing macrophages against cancer

6 years ago

Ansun Biopharma closes $80M Series B; RedHill Biopharma ties up with Cosmo Pharmaceuticals

6 years ago

FDA expands Xofluza approval as Roche struggles to catch looming flu market

6 years ago

Merck KGaA wants to get in early on Chinese innovation — so it's setting up a seed fund there

6 years ago

EMA backs seven therapies, including Merck's Ebola vaccine

6 years ago

Ronald Herbst follows MedImmune exodus to Pyxis CSO post; Jeff Goddard to succeed CEO of AIT Bioscience

6 years ago

Top ALK expert and cancer drug researcher Alice Shaw bids adieu to academia, hello to Novartis

6 years ago

Merck is taking the ax to its US operations, cutting 500 jobs in its latest reorganization

6 years ago

As Osiris moves on from fraudulent past, one exec settles up with SEC

6 years ago

J&J's Xarelto, Amarin's Vascepa are cost-effective, not budget friendly — ICER

6 years ago

After 13% discount Innate Pharma raises $69M; AZTherapies bags $26.3M from Series C financing round

6 years ago

PhI fizzle forces Syros to spike its lead drug, triggering another rout on shares

6 years ago

Mirati preps its first look at their KRAS G12C contender, and they have to clear a high bar for success

6 years ago

UCB tries to win some respect in the crowded psoriasis market with a dual IL-17 approach — and it won't be easy

6 years ago

Sofinnova Partners builds stacks [on stacks, on stacks] as fund breaks past $2B mark

6 years ago

Another record year for generic drug approvals but questions on competition remain

6 years ago

Despite worries triggered by imbalance of deaths, Shionogi's antibiotic clears FDA panel vote

6 years ago

The FDA will hustle up an expedited review for AstraZeneca’s next shot at a blockbuster cancer drug franchise

6 years ago

Sean Parker helps create a CRISPRed cell therapy 2.0 play — and he’s got a high-profile set of leaders on the ...

6 years ago

San Diego upstart debuts discovery engine that puts a twist to protein degradation

6 years ago

First page Previous page 888 889 890891892 893 894 Next page Last page